S1141 Colon Cancer Risk Perception in Ulcerative Colitis: Patients Overestimate the Risk, But Disagree with the Therapy von Awais, Dahlia, Swaminath, Arun C, Velayos, Fernando S, Ullman, Thomas A, Isaacs, Kim L, Sharabidze, Annie, Walkup, Dolly, Higgins, Peter D

Volltext

W1250 Early Experience with Adalimumab for the Treatment of IBD in An Academic Medical Center von Swaminath, Arun C, Rosen, Melissa H, Mayer, Lloyd, Ullman, Thomas A, Lichtiger, Simon, Abreu, Maria T

Volltext

CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22 von Longman, Randy S, Diehl, Gretchen E, Victorio, Daniel A, Huh, Jun R, Galan, Carolina, Miraldi, Emily R, Swaminath, Arun, Bonneau, Richard, Scherl, Ellen J, Littman, Dan R

Volltext

Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians von Buckley, Megan C., Kumar, Anand, Swaminath, Arun

Volltext

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease von Dulai, Parambir S., Boland, Brigid S., Singh, Siddharth, Chaudrey, Khadija, Koliani-Pace, Jenna L., Kochhar, Gursimran, Parikh, Malav P., Shmidt, Eugenia, Hartke, Justin, Chilukuri, Prianka, Meserve, Joseph, Whitehead, Diana, Hirten, Robert, Winters, Adam C., Katta, Leah G., Peerani, Farhad, Narula, Neeraj, Sultan, Keith, Swaminath, Arun, Bohm, Matthew, Lukin, Dana, Hudesman, David, Chang, John T., Rivera-Nieves, Jesus, Jairath, Vipul, Zou, G.Y., Feagan, Brian G., Shen, Bo, Siegel, Corey A., Loftus, Edward V., Kane, Sunanda, Sands, Bruce E., Colombel, Jean-Frederic, Sandborn, William J., Lasch, Karen, Cao, Charlie

Volltext

ENDOSCOPIC VERSUS SURGICAL RESECTION IN THE TREATMENT OF T1B ESOPHAGEAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS von Kumar, Anand, Inra, Matthew, Newman, Elliot, Chandan, Saurabh, McCabe, Evin J., Swaminath, Arun, Trindade, Arvind J., Benias, Petros C., Robbins, David H.

Volltext

Su1828 PRECISION DOSING TEST FOR OPTIMIZING ADALIMUMAB IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EVIDENCE STUDY von Hanauer, Stephen B., Torres, Esther A., Swaminath, Arun, Lee, Thomas C., Rabizadeh, Shervin, Check, Morgan S., Barrett, Terrence, Chapman, Casey, Arai, Ronen, Hashash, Jana G., Butnariu, Madalina, Meister, Thomas, Kinnucan, Jami A., Yen, Eugene F., Stein, Daniel J., Sinh, Preetika, Ziring, David, Sharposhnikov, Rimma, Qazi, Taha, Yarur, Andres, Han, Patricia Aragon, Abraham, Bincy P.

Volltext

Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK) von Lalani, Aly-Khan A., Swaminath, Anand, Pond, Gregory Russell, Morgan, Scott C., Azad, Arun, Chu, William, Kapoor, Anil, Bonert, Michael, Bramson, Jonathan L., Surette, Michael G., Bosse, Dominick, Siva, Shankar, Bjarnason, Georg A., Gopaul, Darin, Basappa, Naveen S., Wright, Jim, Hotte, Sebastien J.

Volltext

Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case von Goldfeld, Dahlia A., Verna, Elizabeth C., Lefkowitch, Jay, Swaminath, Arun

Volltext

611 THE REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN THE TREATMENT OF CROHN'S DISEASE von Johnson, Amanda M., Barsky, Maria, Ahmed, Waseem, Zullow, Samantha, Galati, Jonathan S., Jairath, Vipul, Narula, Neeraj, Peerani, Farhad, Click, Benjamin H., Coburn, Elliot, Dang, Thucnhi T., Gold, Stephanie, Agrawal, Manasi, Garg, Rajat, Aggarwal, Manik, Mohammad, Danah, Halloran, Brendan P., Kochhar, Gursimran, Todorowski, Hannah, Mohy-Ud-Din, Nabeeha, Izanec, James L., Teeple, Amanda M., Gasink, Christopher, Muser, Erik, Ding, Zhijie, Swaminath, Arun, Lakhani, Komal, Hogan, Daniel, Datta, Samit, Ungaro, Ryan C., Singh, Siddharth, Boland, Brigid, Bohm, Matthew, Fischer, Monika, Sashi, Sagi, Afzali, Anita, Ullman, Thomas, Lawlor, Garrett, Baumgart, Daniel C., Chang, Shannon, Hudesman, David, Lukin, Dana J., Scherl, Ellen J., Colombel, Jean Frederic, Sands, Bruce E., Siegel, Corey A., Regueiro, Miguel D., Sandborn, William J., Bruining, David H., Kane, Sunanda V., Loftus, Edward V., Dulai, Parambir

Volltext

334 – Development and Validation of a Clinical Scoring Tool for Predicting Treatment Outcomes with Vedolizumab in Patients with Ulcerative Colitis von Dulai, Parambir S., Singh, Siddharth, Casteele, Niels Vande, Meserve, Joseph, Winters, Adam C., Chablaney, Shreya, Aniwan, Satimai, Shashi, Preeti, Kochhar, Gursimran, Weiss, Aaron, Koliani-Pace, Jenna, Gao, Youran, Boland, Brigid S., Chang, John T., Faleck, David, Hirten, Robert, Ungaro, Ryan C., Lukin, Dana, Keith, Sultan, Hudesman, David, Chang, Shannon, Bohm, Matthew, Varma, Sashidhar, Fischer, Monika, Shmidt, Eugenia, Swaminath, Arun, Gupta, Nitin, Rosario, Maria, Jairath, Vipul, Guizzetti, Leonardo, Feagan, Brian G., Siegel, Corey A., Shen, Bo, Kane, Sunanda V., Loftus, Edward V., Sandborn, William J., Sands, Bruce E., Colombel, Jean Frederic, Lasch, Karen, Cao, Charlie

Volltext

Su461 SHORTER DISEASE DURATION IN PATIENTS WITH CROHN'S DISEASE IS ASSOCIATED WITH HIGHER RATES OF REMISSION WITH USTEKINUMAB von Gold, Stephanie, Agrawal, Manasi, Jairath, Vipul, Galati, Jonathan S., Coburn, Elliot, Click, Benjamin H., Peerani, Farhad, Narula, Neeraj, Zullow, Samantha, Ahmed, Waseem, Barsky, Maria, Johnson, Amanda M., Dang, Thucnhi T., Garg, Rajat, Aggarwal, Manik, Mohammad, Danah, Halloran, Brendan P., Kochhar, Gursimran, Todorowski, Hannah, Mohy-Ud-Din, Nabeeha, Izanec, James L., Teeple, Amanda M., Gasink, Christopher, Muser, Erik, Ding, Zhijie, Swaminath, Arun, Lakhani, Komal, Hogan, Daniel, Datta, Samit, Singh, Siddharth, Boland, Brigid, Bohm, Matthew, Fischer, Monika, Sashi, Sagi, Bruining, David H., Kane, Sunanda V., Loftus, Edward V., Afzali, Anita, Ullman, Thomas, Lawlor, Garrett, Baumgart, Daniel C., Chang, Shannon, Hudesman, David, Lukin, Dana J., Sandborn, William J., Scherl, Ellen J., Siegel, Corey A., Regueiro, Miguel D., Colombel, Jean Frederic, Sands, Bruce E., Dulai, Parambir, Ungaro, Ryan C.

Volltext